首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Efficacy of Mamsyadi Ghana capsule and Saraswatarista in the management of Insomnia Disorder - A Randomized Controlled Clinical Trial 加纳玛斯亚迪胶囊与沙参治疗失眠症的临床随机对照试验
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101160
M. Manasa , Aswini Padmashali , Basavaraj R. Tubaki , Manisha

Background

One of the prevalent sleep disorders is insomnia disorder. Current pharmacotherapy have limitations like dependence, tolerance and withdrawal effects. Ayurveda drugs remains to be explored.

Objectives

Can Ayurveda intervention (Mamsyadi Ghana Capsule and Saraswatharista) play a role in Insomnia disorder.

Material and Methods

50 patients meeting the diagnostic criteria of Insomnia Disorder (DSM 5), age group 20–70 years, either sex participated in the study. They were randomly divided and Ayurveda group received Mamsyadi Ghana Capsule 500 mg, Saraswatharista 10 ml, with equal quantity of water after food, both thrice a day for 30 days. Zolpidem group received tablet Zolpidem 10 mg once a day at bed time. Evaluations were done through Insomnia severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness scale (ESS), Sleep diary parameters, Depression Anxiety and Stress Scale (DASS), Quality of Life – SF 36 Questionnaire and UKU side effect rating scale. Clinical assessments were at baseline, 15th and 30th day.

Results

The study showed that Ayurveda intervention produced significant improvement and was comparable to Zolpidem. Both interventions were comparable in ISI, PSQI, ESS, DASS scale, sleep diary parameters and most of the components of SF-36. Role of limitations due to emotional problems component showed better improvement in Ayurveda group (p = 0.01). Within group analysis showed improvement in both the groups. Five patients had adverse effects with Zolpidem and nil with ayurveda group.

Conclusions

The study showed that effect of Ayurveda interventions (Mamsyadi Ghana Capsule and Saraswatharista) is comparable to zolpidem in Insomnia Disorder. Ayurveda intervention had better improvement on quality of life and had good safety profile.

Ctri registration number

CTRI/2021/12/038809.
背景失眠是常见的睡眠障碍之一。目前的药物治疗存在依赖性、耐受性和戒断效应等局限性。阿育吠陀药物仍有待探索。目的探讨阿育吠陀干预(Mamsyadi Ghana胶囊和saraswatharida)对失眠障碍的治疗作用。材料与方法50例符合失眠症诊断标准(DSM 5)的患者,年龄20 ~ 70岁,男女不限。随机分组,阿育吠陀组给予Mamsyadi Ghana胶囊500 mg, Saraswatharista 10 ml,餐后等量水,每天3次,连用30天。唑吡坦组患者给予唑吡坦片10 mg,每日1次,睡前服用。通过失眠严重程度指数(ISI)、匹兹堡睡眠质量指数(PSQI)、Epworth嗜睡量表(ESS)、睡眠日记参数、抑郁、焦虑和压力量表(DASS)、生活质量SF - 36问卷和UKU副作用评定量表进行评估。临床评估分别在基线、第15天和第30天进行。结果阿育吠陀干预治疗效果显著,与唑吡坦相当。两种干预措施在ISI、PSQI、ESS、DASS量表、睡眠日记参数和SF-36的大部分成分方面具有可比性。阿育吠陀治疗组因情绪问题导致的限制作用成分有较好的改善(p = 0.01)。组内分析显示两组均有改善。唑吡坦组不良反应5例,阿育吠陀组无不良反应。结论阿育吠陀治疗失眠症的效果与唑吡坦相当。阿育吠陀干预对患者的生活质量有较好的改善,且具有良好的安全性。Ctri注册号Ctri /2021/12/038809。
{"title":"Efficacy of Mamsyadi Ghana capsule and Saraswatarista in the management of Insomnia Disorder - A Randomized Controlled Clinical Trial","authors":"M. Manasa ,&nbsp;Aswini Padmashali ,&nbsp;Basavaraj R. Tubaki ,&nbsp;Manisha","doi":"10.1016/j.jaim.2025.101160","DOIUrl":"10.1016/j.jaim.2025.101160","url":null,"abstract":"<div><h3>Background</h3><div>One of the prevalent sleep disorders is insomnia disorder. Current pharmacotherapy have limitations like dependence, tolerance and withdrawal effects. Ayurveda drugs remains to be explored.</div></div><div><h3>Objectives</h3><div>Can Ayurveda intervention (<em>Mamsyadi Ghana</em> Capsule and <em>Saraswatharista</em>) play a role in Insomnia disorder.</div></div><div><h3>Material and Methods</h3><div>50 patients meeting the diagnostic criteria of Insomnia Disorder (DSM 5), age group 20–70 years, either sex participated in the study. They were randomly divided and Ayurveda group received <em>Mamsyadi Ghana</em> Capsule 500 mg, <em>Saraswatharista</em> 10 ml, with equal quantity of water after food, both thrice a day for 30 days. Zolpidem group received tablet Zolpidem 10 mg once a day at bed time. Evaluations were done through Insomnia severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness scale (ESS), Sleep diary parameters, Depression Anxiety and Stress Scale (DASS), Quality of Life – SF 36 Questionnaire and UKU side effect rating scale. Clinical assessments were at baseline, 15th and 30th day.</div></div><div><h3>Results</h3><div>The study showed that Ayurveda intervention produced significant improvement and was comparable to Zolpidem. Both interventions were comparable in ISI, PSQI, ESS, DASS scale, sleep diary parameters and most of the components of SF-36. Role of limitations due to emotional problems component showed better improvement in Ayurveda group (p = 0.01). Within group analysis showed improvement in both the groups. Five patients had adverse effects with Zolpidem and nil with ayurveda group.</div></div><div><h3>Conclusions</h3><div>The study showed that effect of Ayurveda interventions (<em>Mamsyadi Ghana</em> Capsule and <em>Saraswatharista</em>) is comparable to zolpidem in Insomnia Disorder. Ayurveda intervention had better improvement on quality of life and had good safety profile.</div></div><div><h3>Ctri registration number</h3><div>CTRI/2021/12/038809.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101160"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144572111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayush at crossroads - A challenge of opportunities 阿尤什站在十字路口——机遇的挑战
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101254
Girish Tillu
{"title":"Ayush at crossroads - A challenge of opportunities","authors":"Girish Tillu","doi":"10.1016/j.jaim.2025.101254","DOIUrl":"10.1016/j.jaim.2025.101254","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101254"},"PeriodicalIF":1.9,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144828741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroprotective potential of dombeya wallichii ameliorates Parkinson's activity in paraquat-induced Rat's model via modulation of neuro-inflammatory cytokines 在百草枯诱导的大鼠帕金森病模型中,白桦的神经保护潜力通过调节神经炎性细胞因子改善帕金森病的活性
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101162
Hafsa Tariq , Khizra Ishfaq , Talha Chauhdari , Fatima Sarwar , Fazeela Ismail

Background

Parkinson's disease (PD) is a prevalent age-related neurodegenerative condition that develops gradually and is observed in around 1 % of the elderly population. Lately, there has been an increasing curiosity about the possibilities of phyto-components for the treatment of PD due to their rich array of active compounds, notably antioxidants and anti-inflammatory agents.

Objective

Our objective was to assess the impact of an ethanolic extract from Dombeya wallichii, which has antioxidant properties, on the Parkinsonian rat's model.

Material and methods

Rats received 10 mg/kg paraquat to assess its antiparkinsonian effects. They were treated with ethanolic extract of Dombeya wallichii (200, 400, 600 mg/kg) for 21 days, 1 h after paraquat. Behavioral aspects were evaluated before sacrifice. On day 22, rats were euthanized, and their bodies examined for changes in antioxidant enzymes (superoxide dismutase, glutathione, malondialdehyde, catalase), neurotransmitter levels (dopamine, noradrenaline, serotonin, acetylcholinesterase), mRNA expression and neuroinflammatory cytokines (Interleukin-1β, Tumor Necrosis Factor-α, nuclear factor kappa B, Interleukin-6).

Results

The ethanolic extract of Dombeya wallichii reduced paraquat-induced motor deficits in the rotarod, hole board, akinesia, and forelimb hanging tests. It also improved biochemical and neuroinflammatory markers by lowering oxidative stress and inflammatory cytokines, showing antioxidant and anti-inflammatory activities. q-RT-PCR revealed that D. wallichii downregulated α-synuclein, Interleukin-1β, nuclear factor kappa B, and Tumor Necrosis Factor-α, while mRNA expression indicated neuroprotection.

Conclusion

These findings suggest that Dombeya wallichii could be a viable candidate for Parkinson's disease treatment, owing to its antioxidant and anti-inflammatory properties.
帕金森病(PD)是一种普遍的与年龄相关的神经退行性疾病,其逐渐发展,约占老年人口的1%。最近,人们对植物成分治疗帕金森病的可能性越来越好奇,因为它们含有丰富的活性化合物,特别是抗氧化剂和抗炎剂。目的:我们的目的是评估具有抗氧化特性的东贝亚(Dombeya wallichii)乙醇提取物对帕金森大鼠模型的影响。材料与方法大鼠接受10 mg/kg百草枯治疗,观察其抗帕金森病作用。百草枯处理后1 h,分别用200、400、600 mg/kg的白桦醇提物处理21 d。献祭前对行为方面进行评估。第22天,对大鼠实施安乐死,检测其体内抗氧化酶(超氧化物歧化酶、谷胱甘肽、丙二醛、过氧化氢酶)、神经递质(多巴胺、去甲肾上腺素、血清素、乙酰胆碱酯酶)、mRNA表达和神经炎性细胞因子(白细胞介素-1β、肿瘤坏死因子-α、核因子κ B、白细胞介素-6)的变化。结果白桦醇提物对百草枯致大鼠旋转、孔板、运动障碍、前肢悬吊等运动障碍有明显的减轻作用。它还通过降低氧化应激和炎症细胞因子来改善生化和神经炎症标志物,显示出抗氧化和抗炎活性。q-RT-PCR结果显示,白介素-1β、核因子κ B和肿瘤坏死因子-α下调,mRNA表达具有神经保护作用。结论该植物具有抗氧化和抗炎作用,可能是治疗帕金森病的可行候选药物。
{"title":"Neuroprotective potential of dombeya wallichii ameliorates Parkinson's activity in paraquat-induced Rat's model via modulation of neuro-inflammatory cytokines","authors":"Hafsa Tariq ,&nbsp;Khizra Ishfaq ,&nbsp;Talha Chauhdari ,&nbsp;Fatima Sarwar ,&nbsp;Fazeela Ismail","doi":"10.1016/j.jaim.2025.101162","DOIUrl":"10.1016/j.jaim.2025.101162","url":null,"abstract":"<div><h3>Background</h3><div>Parkinson's disease (PD) is a prevalent age-related neurodegenerative condition that develops gradually and is observed in around 1 % of the elderly population. Lately, there has been an increasing curiosity about the possibilities of phyto-components for the treatment of PD due to their rich array of active compounds, notably antioxidants and anti-inflammatory agents.</div></div><div><h3>Objective</h3><div>Our objective was to assess the impact of an ethanolic extract from <em>Dombeya wallichii</em>, which has antioxidant properties, on the Parkinsonian rat's model.</div></div><div><h3>Material and methods</h3><div>Rats received 10 mg/kg paraquat to assess its antiparkinsonian effects. They were treated with ethanolic extract of <em>Dombeya wallichii</em> (200, 400, 600 mg/kg) for 21 days, 1 h after paraquat. Behavioral aspects were evaluated before sacrifice. On day 22, rats were euthanized, and their bodies examined for changes in antioxidant enzymes (superoxide dismutase, glutathione, malondialdehyde, catalase), neurotransmitter levels (dopamine, noradrenaline, serotonin, acetylcholinesterase), mRNA expression and neuroinflammatory cytokines (Interleukin-1β, Tumor Necrosis Factor-α, nuclear factor kappa B, Interleukin-6).</div></div><div><h3>Results</h3><div>The ethanolic extract of <em>Dombeya wallichii</em> reduced paraquat-induced motor deficits in the rotarod, hole board, akinesia, and forelimb hanging tests. It also improved biochemical and neuroinflammatory markers by lowering oxidative stress and inflammatory cytokines, showing antioxidant and anti-inflammatory activities. q-RT-PCR revealed that <em>D. wallichii</em> downregulated α-synuclein, Interleukin-1β, nuclear factor kappa B, and Tumor Necrosis Factor-α, while mRNA expression indicated neuroprotection.</div></div><div><h3>Conclusion</h3><div>These findings suggest that <em>Dombeya wallichii</em> could be a viable candidate for Parkinson's disease treatment, owing to its antioxidant and anti-inflammatory properties.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101162"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In-silico docking analysis of bioactive compounds sourced from Punica granatum peel extract: Approaching a precision solution for ovarian cancer 来自石榴皮提取物的生物活性化合物的硅对接分析:接近卵巢癌的精确解决方案
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101125
Swarupa Hatolkar , Aishwarya Patil , Hiramoni Lahkar , Poulomi Chakraborty , Bhagyashree Vinit Gokhale , Aarti Shastri

Background

The MAPK signalling pathways, particularly those involving EGFR and VEGFR, play a pivotal role in the initiation and progression of ovarian cancer. Inadequate regulation of these pathways may lead to uncontrolled cell proliferation, angiogenesis, and metastasis. Targeting mitogen-activated protein kinases (MAPKs), including the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR), has demonstrated significant potential in restraining cancer cell proliferation and angiogenesis, representing a promising avenue among various therapeutic strategies.

Objectives

This manuscript aims to investigate the possibility of Mashi a pomegranate peel extract for ovarian cancer treatment, specifically targeting MAPKs (EGFR and VEGFR). Pomegranate (Punica granatum) is a well-known fruit whose varied portions have been used in traditional medicine for ages.

Materials and methods

In silico docking of bioactive compounds extracted from the pomegranate peel extract was done using the Autodock 4.2.6 software. A total of 10 two-dimensional ligands were generated with Pubchem site. The targeted proteins VEGFR, EGFR, MAPK, and MAPK8 were docked with the ligands (Sphondin, Isorhamnetin, Lupinine, Ellagic acid, and Citric acid) which were bioactive ingredients identified from pomegranate peel extract.

Results

It was observed that the binding energy of protein MAPK 8, MAPK 14, and VGFR was higher to the ligand at ellagic acid at -8.25kcal/mol, -7.61kcal/mol, and - 5.85kcal/mol respectively. However, EGFR observed to bind with ligand Isorhamnetin at -7.48kcal/mol.

Conclusion

The MAPK signalling pathways, specifically involving EGFR and VEGFR, play a crucial role in the initiation and dissemination of ovarian cancer. Dysregulation of these pathways can lead to unrestrained cell proliferation, angiogenesis, and metastasis. Our study revealed favorable binding energy between targeted proteins and ligands. Consequently, we infer that proteins exhibiting robust binding energy with bioactive compounds from pomegranate peel extract may exert regulatory control over the signalling pathways. This implies that EGFR and VEGFR can modulate signals by binding to the bioactive compounds in pomegranate peel extract, thereby regulating the MAPK pathway and ultimately curtailing uncontrolled cell proliferation, angiogenesis, and tumor metastasis. supported by simulation studies results.
MAPK信号通路,特别是那些涉及EGFR和VEGFR的信号通路,在卵巢癌的发生和发展中起着关键作用。这些途径的调节不足可能导致不受控制的细胞增殖、血管生成和转移。靶向丝裂原活化蛋白激酶(MAPKs),包括表皮生长因子受体(EGFR)和血管内皮生长因子受体(VEGFR),已经显示出抑制癌细胞增殖和血管生成的巨大潜力,在各种治疗策略中代表了一个有前途的途径。目的探讨石榴皮提取物麻石用于卵巢癌治疗的可能性,特别是针对MAPKs (EGFR和VEGFR)。石榴(石榴)是一种众所周知的水果,其不同的部分已经在传统医学中使用了很长时间。材料与方法采用Autodock 4.2.6软件对石榴皮提取物中提取的活性物质进行硅对接。利用Pubchem site共生成了10个二维配体。靶蛋白VEGFR、EGFR、MAPK和MAPK8与从石榴皮提取物中鉴定出的生物活性成分配体(Sphondin、Isorhamnetin、Lupinine、鞣花酸和柠檬酸)对接。结果mapk8、mapk14和VGFR蛋白与鞣花酸配体的结合能分别为-8.25kcal/mol、-7.61kcal/mol和- 5.85kcal/mol。然而,EGFR以-7.48kcal/mol的速率与异鼠李素结合。结论MAPK信号通路,特别是EGFR和VEGFR,在卵巢癌的发生和传播中起着至关重要的作用。这些通路的失调可导致无限制的细胞增殖、血管生成和转移。我们的研究揭示了靶蛋白和配体之间有利的结合能。因此,我们推断,与石榴皮提取物中生物活性化合物具有强大结合能的蛋白质可能对信号通路施加调节控制。这表明EGFR和VEGFR可以通过与石榴皮提取物中的生物活性化合物结合来调节信号,从而调节MAPK通路,最终抑制不受控制的细胞增殖、血管生成和肿瘤转移。得到仿真研究结果的支持。
{"title":"In-silico docking analysis of bioactive compounds sourced from Punica granatum peel extract: Approaching a precision solution for ovarian cancer","authors":"Swarupa Hatolkar ,&nbsp;Aishwarya Patil ,&nbsp;Hiramoni Lahkar ,&nbsp;Poulomi Chakraborty ,&nbsp;Bhagyashree Vinit Gokhale ,&nbsp;Aarti Shastri","doi":"10.1016/j.jaim.2025.101125","DOIUrl":"10.1016/j.jaim.2025.101125","url":null,"abstract":"<div><h3>Background</h3><div>The MAPK signalling pathways, particularly those involving EGFR and VEGFR, play a pivotal role in the initiation and progression of ovarian cancer. Inadequate regulation of these pathways may lead to uncontrolled cell proliferation, angiogenesis, and metastasis. Targeting mitogen-activated protein kinases (MAPKs), including the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR), has demonstrated significant potential in restraining cancer cell proliferation and angiogenesis, representing a promising avenue among various therapeutic strategies.</div></div><div><h3>Objectives</h3><div>This manuscript aims to investigate the possibility of Mashi a pomegranate peel extract for ovarian cancer treatment, specifically targeting MAPKs (EGFR and VEGFR). Pomegranate (Punica granatum) is a well-known fruit whose varied portions have been used in traditional medicine for ages.</div></div><div><h3>Materials and methods</h3><div>In silico docking of bioactive compounds extracted from the pomegranate peel extract was done using the Autodock 4.2.6 software. A total of 10 two-dimensional ligands were generated with Pubchem site. The targeted proteins VEGFR, EGFR, MAPK, and MAPK8 were docked with the ligands (Sphondin, Isorhamnetin, Lupinine, Ellagic acid, and Citric acid) which were bioactive ingredients identified from pomegranate peel extract.</div></div><div><h3>Results</h3><div>It was observed that the binding energy of protein MAPK 8, MAPK 14, and VGFR was higher to the ligand at ellagic acid at -8.25kcal/mol, -7.61kcal/mol, and - 5.85kcal/mol respectively. However, EGFR observed to bind with ligand Isorhamnetin at -7.48kcal/mol.</div></div><div><h3>Conclusion</h3><div>The MAPK signalling pathways, specifically involving EGFR and VEGFR, play a crucial role in the initiation and dissemination of ovarian cancer. Dysregulation of these pathways can lead to unrestrained cell proliferation, angiogenesis, and metastasis. Our study revealed favorable binding energy between targeted proteins and ligands. Consequently, we infer that proteins exhibiting robust binding energy with bioactive compounds from pomegranate peel extract may exert regulatory control over the signalling pathways. This implies that EGFR and VEGFR can modulate signals by binding to the bioactive compounds in pomegranate peel extract, thereby regulating the MAPK pathway and ultimately curtailing uncontrolled cell proliferation, angiogenesis, and tumor metastasis. supported by simulation studies results.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101125"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameliorative effect of Inula racemosa Hook. F root extract against diethylnitrosamine induced hepatic damage in murine model 总状菊的改良作用。七根提取物对二乙基亚硝胺致小鼠肝损伤的保护作用
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101173
Smriti Jamwal , Rakesh Kumar , R.K. Asrani , Ankita , Abhishek Verma , Ekta Bisht , Shreya Katoch , Vikram Patial , Vinesh Sharma , Adarsh Kumar , R.D. Patil

Background

Liver disease is one of the most serious health problems worldwide. In the present scenario, the available therapies for liver ailments are not very effective and systemic toxicity inhibits their long-term use. Several medicinal plants have demonstrated promising effects against liver damage. These plants can help to prevent liver injury, reduce inflammation, enhance liver detoxification, and support liver cell regeneration and one such medicinal plant is Inula racemosa. The bioactive constituents present in the root extract of Inula racemosa i.e. alantolactone and isoalantolactone are responsible for its hepatoprotective potential.

Objectives

The current study aimed to elucidate the preventive action of Inula racemosa root extract against chemically-induced liver damage using Diethylnitrosamine (DEN).

Material and methods

Sprague Dawley (SD) 42-male rats were used in a 10-week study to examine the hepatoprotective effects of 3 different dosages (100, 250, and 500 mg/kg body weight) of Inula racemosa root extract against DEN-induced liver damage. The investigation included gross pathology, histopathology, immunohistochemistry (TGF-β and NF- κB), ultrasonography, and serum biochemistry (ALT, AST, ALP, Total protein, Albumin, Creatinine, and BUN).

Results

The in vivo research establishes Inula racemosa root extract's hepatoprotective efficacy by ameliorating biochemical parameters, lipid peroxidation, gross and histopathological alterations, and reduced immunohistochemical expression of TGF-β and NF- κB. The greatest defense against chemically-induced liver damage was provided by the highest dosage of the extract i.e. 500 mg/kg body weight.

Conclusions

The results of this investigation showed that the Inula racemosa root extract showed hepatoprotective activity against DEN-induced liver damage in the rat model.
背景肝病是世界范围内最严重的健康问题之一。在目前的情况下,现有的治疗肝病的方法不是很有效,而且全身毒性抑制了它们的长期使用。一些药用植物已经证明对肝损伤有很好的效果。这些植物可以帮助预防肝损伤,减少炎症,增强肝脏解毒,并支持肝细胞再生,其中一种药用植物是总状菊。总状菊根提取物中存在的生物活性成分,即alantolactone和异alantolactone具有保护肝脏的潜力。目的研究总状菊根提取物对化学诱导的二乙基亚硝胺(DEN)肝损伤的预防作用。材料与方法采用SD (sprague Dawley, SD) 42只雄性大鼠进行为期10周的实验,研究3种不同剂量(100、250和500 mg/kg体重)总状菊根提取物对den诱导的肝损伤的保护作用。检查方法包括大体病理、组织病理、免疫组织化学(TGF-β、NF- κB)、超声、血清生化(ALT、AST、ALP、总蛋白、白蛋白、肌酐、BUN)。结果总状菊根提取物通过改善生化指标、脂质过氧化、肉眼和组织病理学改变、降低TGF-β和NF- κB的免疫组织化学表达,在体内证实了总状菊根提取物的肝保护作用。对化学诱导的肝损伤的最大防御是最高剂量的提取物,即500毫克/公斤体重。结论总状菊根提取物对den诱导的大鼠肝损伤具有保护肝脏的作用。
{"title":"Ameliorative effect of Inula racemosa Hook. F root extract against diethylnitrosamine induced hepatic damage in murine model","authors":"Smriti Jamwal ,&nbsp;Rakesh Kumar ,&nbsp;R.K. Asrani ,&nbsp;Ankita ,&nbsp;Abhishek Verma ,&nbsp;Ekta Bisht ,&nbsp;Shreya Katoch ,&nbsp;Vikram Patial ,&nbsp;Vinesh Sharma ,&nbsp;Adarsh Kumar ,&nbsp;R.D. Patil","doi":"10.1016/j.jaim.2025.101173","DOIUrl":"10.1016/j.jaim.2025.101173","url":null,"abstract":"<div><h3>Background</h3><div>Liver disease is one of the most serious health problems worldwide. In the present scenario, the available therapies for liver ailments are not very effective and systemic toxicity inhibits their long-term use. Several medicinal plants have demonstrated promising effects against liver damage. These plants can help to prevent liver injury, reduce inflammation, enhance liver detoxification, and support liver cell regeneration and one such medicinal plant is <em>Inula racemosa.</em> The bioactive constituents present in the root extract of <em>Inula racemosa</em> i.e. alantolactone and isoalantolactone are responsible for its hepatoprotective potential.</div></div><div><h3>Objectives</h3><div>The current study aimed to elucidate the preventive action of <em>Inula racemosa</em> root extract against chemically-induced liver damage using Diethylnitrosamine (DEN).</div></div><div><h3>Material and methods</h3><div>Sprague Dawley (SD) 42-male rats were used in a 10-week study to examine the hepatoprotective effects of 3 different dosages (100, 250, and 500 mg/kg body weight) of <em>Inula racemosa</em> root extract against DEN-induced liver damage. The investigation included gross pathology, histopathology, immunohistochemistry (TGF-β and NF- κB), ultrasonography, and serum biochemistry (ALT, AST, ALP, Total protein, Albumin, Creatinine, and BUN).</div></div><div><h3>Results</h3><div>The <em>in vivo</em> research establishes <em>Inula racemosa</em> root extract's hepatoprotective efficacy by ameliorating biochemical parameters, lipid peroxidation, gross and histopathological alterations, and reduced immunohistochemical expression of TGF-β and NF- κB. The greatest defense against chemically-induced liver damage was provided by the highest dosage of the extract i.e. 500 mg/kg body weight.</div></div><div><h3>Conclusions</h3><div>The results of this investigation showed that the <em>Inula racemosa</em> root extract showed hepatoprotective activity against DEN-induced liver damage in the rat model.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101173"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144579650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-invasive management of Thandaga vaatham (lumbar spondylosis) through Siddha Varmam therapy - A case report 通过Siddha Varmam治疗腰椎病无创治疗1例
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101171
Shunmugaram Shenbagaraj, Saraswathi Balasubramanian, Deepa Ravichandran, Vinodini Ramamoorthy, Sathiyarajeswaran Parameswaran, Shyamala Rajkumar
A 32-year-old female homemaker came with a complaints of chronic low back pain, radiating to both lower limbs, stiffness especially in the morning difficulty in walking and standing with intensified pain during household chores for two years. She was diagnosed with Tantaka vātam, one of the eighty types of vātam disease which is equivalent to lumbar spondylosis. She was treated with therapeutic Varmam manipulations in every 7 days for a period of 48 days and followed for six months. Oswestry Disability Index, Siddha based diagnostic parameters were used to assess the clinical efficacy and no adverse events were noted during the treatment course and follow up period. This case report has provided a promising non-invasive and cost-effective therapeutic indication for the management of Tantaka vātam (lumbar spondylosis).
女性,32岁,家庭主妇,主诉慢性腰痛,双下肢放射,晨起僵直,行走站立困难,家务劳动时疼痛加重,两年。她被诊断为Tantaka vātam,这是80种vātam疾病中的一种,相当于腰椎病。采用治疗性Varmam手法治疗,每7天治疗一次,连续48天,随访6个月。采用Oswestry残疾指数、Siddha诊断参数评价临床疗效,治疗过程及随访期间均无不良事件发生。本病例报告为Tantaka vātam(腰椎病)的治疗提供了一种有希望的无创和经济有效的治疗指征。
{"title":"Non-invasive management of Thandaga vaatham (lumbar spondylosis) through Siddha Varmam therapy - A case report","authors":"Shunmugaram Shenbagaraj,&nbsp;Saraswathi Balasubramanian,&nbsp;Deepa Ravichandran,&nbsp;Vinodini Ramamoorthy,&nbsp;Sathiyarajeswaran Parameswaran,&nbsp;Shyamala Rajkumar","doi":"10.1016/j.jaim.2025.101171","DOIUrl":"10.1016/j.jaim.2025.101171","url":null,"abstract":"<div><div>A 32-year-old female homemaker came with a complaints of chronic low back pain, radiating to both lower limbs, stiffness especially in the morning difficulty in walking and standing with intensified pain during household chores for two years. She was diagnosed with <em>Tantaka vātam,</em> one of the eighty types of vātam disease which is equivalent to lumbar spondylosis. She was treated with therapeutic <em>Varmam</em> manipulations in every 7 days for a period of 48 days and followed for six months. Oswestry Disability Index, Siddha based diagnostic parameters were used to assess the clinical efficacy and no adverse events were noted during the treatment course and follow up period. This case report has provided a promising non-invasive and cost-effective therapeutic indication for the management of <em>Tantaka vātam</em> (lumbar spondylosis).</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101171"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144579651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda management of severe coronary artery calcification in a triple vessel disease patient - a case report 阿育吠陀治疗三支血管疾病患者严重冠状动脉钙化1例
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101165
Divya Kajaria, Punam N. Khobarkar
The coronary artery calcium score is a tool for predicting the risk of coronary artery disease (CAD). Severe coronary artery calcification, particularly in the context of triple vessel disease, poses a considerable therapeutic difficulty for standard medical procedures. The treatment modality for heavily calcified coronary arteries is coronary stenting or coronary artery bypass grafting. Severe calcification reduces the efficacy of stent deployment during PCI. Severe coronary calcification complicates the surgical revascularization process, often leading to increased procedural risks and reduced long-term success rates. A 65-year-old female patient having severe coronary artery calcification (triple vessel disease) is treated with holistic Ayurveda management. It is observed that there is a 17.78 % decrease in the calcium score after purgation therapy and an additional 25.01 % decrease in the calcium score after Rasayana therapy.
冠状动脉钙评分是预测冠状动脉疾病(CAD)风险的一种工具。严重的冠状动脉钙化,特别是在三支血管疾病的情况下,给标准医疗程序带来了相当大的治疗困难。冠状动脉重度钙化的治疗方式是冠状动脉支架置入术或冠状动脉旁路移植术。严重的钙化降低了PCI期间支架部署的有效性。严重的冠状动脉钙化使手术血运重建过程复杂化,往往导致手术风险增加和长期成功率降低。一位65岁的女性患者有严重的冠状动脉钙化(三支血管疾病)治疗整体阿育吠陀管理。我们观察到,在净化治疗后,钙评分下降了17.78%,在Rasayana治疗后,钙评分又下降了25.01%。
{"title":"Ayurveda management of severe coronary artery calcification in a triple vessel disease patient - a case report","authors":"Divya Kajaria,&nbsp;Punam N. Khobarkar","doi":"10.1016/j.jaim.2025.101165","DOIUrl":"10.1016/j.jaim.2025.101165","url":null,"abstract":"<div><div>The coronary artery calcium score is a tool for predicting the risk of coronary artery disease (CAD). Severe coronary artery calcification, particularly in the context of triple vessel disease, poses a considerable therapeutic difficulty for standard medical procedures. The treatment modality for heavily calcified coronary arteries is coronary stenting or coronary artery bypass grafting. Severe calcification reduces the efficacy of stent deployment during PCI. Severe coronary calcification complicates the surgical revascularization process, often leading to increased procedural risks and reduced long-term success rates. A 65-year-old female patient having severe coronary artery calcification (triple vessel disease) is treated with holistic Ayurveda management. It is observed that there is a 17.78 % decrease in the calcium score after purgation therapy and an additional 25.01 % decrease in the calcium score after <em>Rasayana</em> therapy.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101165"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144587747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zebrafish models for studying central nervous system effects of Ayurvedic medicinal plants 用斑马鱼模型研究阿育吠陀药用植物对中枢神经系统的影响
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101169
Pallab Chakraborty , Subharthi Pal , David S. Galstyan , Elena V. Petersen , Tamara G. Amstislavskaya , Tatiana O. Kolesnikova , Murilo S. de Abreu , Allan V. Kalueff
Traditional Indian medicine (Ayurveda) has a long history of treating central nervous system (CNS) disorders. Ayurvedic plants are typically rich in flavonoids, lignans, sterols, tannins and alkaloids that exert potent anti-inflammatory, anti-oxidant, neuroprotective and neurotropic effects in both humans and rodents. The zebrafish (Danio rerio) has emerged as a useful model species and a powerful vertebrate in vivo system for CNS disease modeling and drug screening. As zebrafish continue to demonstrate their growing utility for studying a wide range of pharmaceutical therapies, including Chinese and American traditional medicines, here we discuss CNS effects of various Ayurvedic medicinal plants, and how they can be further elucidated using zebrafish models. We also evaluate the existing challenges and limitations of using zebrafish models for studying Ayurvedic pharmacotherapy, as well as outline future directions of translational research in this field.
传统的印度医学(阿育吠陀)在治疗中枢神经系统(CNS)疾病方面有着悠久的历史。阿育吠陀植物通常富含类黄酮、木脂素、甾醇、单宁和生物碱,对人类和啮齿类动物都有有效的抗炎、抗氧化、神经保护和嗜神经作用。斑马鱼(Danio rerio)已成为一种有用的模型物种,也是一种强大的脊椎动物体内系统,用于中枢神经系统疾病建模和药物筛选。随着斑马鱼在包括中国和美国传统药物在内的广泛药物治疗研究中越来越多的应用,我们在这里讨论各种阿育吠陀药用植物的中枢神经系统作用,以及如何利用斑马鱼模型进一步阐明这些作用。我们还评估了使用斑马鱼模型研究阿育吠陀药物治疗的现有挑战和局限性,并概述了该领域未来的转化研究方向。
{"title":"Zebrafish models for studying central nervous system effects of Ayurvedic medicinal plants","authors":"Pallab Chakraborty ,&nbsp;Subharthi Pal ,&nbsp;David S. Galstyan ,&nbsp;Elena V. Petersen ,&nbsp;Tamara G. Amstislavskaya ,&nbsp;Tatiana O. Kolesnikova ,&nbsp;Murilo S. de Abreu ,&nbsp;Allan V. Kalueff","doi":"10.1016/j.jaim.2025.101169","DOIUrl":"10.1016/j.jaim.2025.101169","url":null,"abstract":"<div><div>Traditional Indian medicine (<em>Ayurveda)</em> has a long history of treating central nervous system (CNS) disorders. <em>Ayurvedic</em> plants are typically rich in flavonoids, lignans, sterols, tannins and alkaloids that exert potent anti-inflammatory, anti-oxidant, neuroprotective and neurotropic effects in both humans and rodents. The zebrafish (<em>Danio rerio</em>) has emerged as a useful model species and a powerful vertebrate in vivo system for CNS disease modeling and drug screening. As zebrafish continue to demonstrate their growing utility for studying a wide range of pharmaceutical therapies, including Chinese and American traditional medicines, here we discuss CNS effects of various <em>Ayurvedic</em> medicinal plants, and how they can be further elucidated using zebrafish models. We also evaluate the existing challenges and limitations of using zebrafish models for studying <em>Ayurvedic</em> pharmacotherapy, as well as outline future directions of translational research in this field.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101169"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144570641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Apamarga Kshara Taila on diabetic pressure ulcer – A case report 阿帕玛加治疗糖尿病性压疮1例
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101167
Gopika G, Rajeshwari P.N
Diabetes mellitus is a group of metabolic disorders with chronic hyperglycemia, and Diabetic Pressure Ulcer (DPU) is one of the major complications. DPU develops due to the effect of continuous forces on the distal pulp, causing progressive skin ischemia occurring above bony prominence. 62 million people are affected with diabetes in India, and among that 25 % develop DPU. Neuropathic and ischemic components account for 45 %–60 % of ulcers, which, if untreated, can lead to the risk of amputation. According to Ayurveda, characteristic features of DPU can be correlated with the features of Dushta vrana and treatment can be planned based on Dushta vrana and Madhumehaja vranas. Acharya Susruta highlighted the importance of kshara for wound debridement in treatment of non-healing ulcers. A 63-year-old male with known case of diabetes mellitus for 15 years presented with a wound over the big toe of his right foot. The wound is 9-month-old. It was associated with loss of sensation, swelling, and discoloration. Treatment was given with the external application of Apamarga kshara taila with internal medications for 2 months. The size of the ulcer measuring 1.5cm in length, 1cm in breadth, and 4 cm in depth completely healed by 2 months of treatment. The utilization of Apamarga kshara taila, along with internal medications, has demonstrated significant efficacy in the management of DPU.
糖尿病是一组伴有慢性高血糖的代谢性疾病,糖尿病压疮(DPU)是其主要并发症之一。DPU的发展是由于远端牙髓受到持续的力的影响,导致骨突以上发生进行性皮肤缺血。印度有6200万人患有糖尿病,其中25%患有DPU。神经病变和缺血性成分占溃疡的45% - 60%,如果不治疗,可能导致截肢的风险。根据阿育吠陀的理论,DPU的特征特征可以与心轮特征相关联,可以根据心轮和Madhumehaja心轮来规划治疗。Acharya Susruta强调了kshara在治疗不愈合溃疡时伤口清创的重要性。63岁男性,已知糖尿病患者15年,右脚大脚趾处有伤口。伤口是9个月大的。它与感觉丧失、肿胀和变色有关。治疗方法为外敷阿帕玛加,内服药物治疗2个月。溃疡长1.5cm,宽1cm,深4cm,经过2个月的治疗,溃疡完全愈合。使用Apamarga kshara taila,连同内部药物,已证明在DPU的管理显著疗效。
{"title":"Effects of Apamarga Kshara Taila on diabetic pressure ulcer – A case report","authors":"Gopika G,&nbsp;Rajeshwari P.N","doi":"10.1016/j.jaim.2025.101167","DOIUrl":"10.1016/j.jaim.2025.101167","url":null,"abstract":"<div><div>Diabetes mellitus is a group of metabolic disorders with chronic hyperglycemia, and Diabetic Pressure Ulcer (DPU) is one of the major complications. DPU develops due to the effect of continuous forces on the distal pulp, causing progressive skin ischemia occurring above bony prominence. 62 million people are affected with diabetes in India, and among that 25 % develop DPU. Neuropathic and ischemic components account for 45 %–60 % of ulcers, which, if untreated, can lead to the risk of amputation. According to Ayurveda, characteristic features of DPU can be correlated with the features of <em>Dushta vrana</em> and treatment can be planned based on <em>Dushta vrana</em> and <em>Madhumehaja vranas</em>. Acharya Susruta highlighted the importance of <em>kshara</em> for wound debridement in treatment of non-healing ulcers. A 63-year-old male with known case of diabetes mellitus for 15 years presented with a wound over the big toe of his right foot. The wound is 9-month-old. It was associated with loss of sensation, swelling, and discoloration. Treatment was given with the external application of <em>Apamarga kshara taila</em> with internal medications for 2 months. The size of the ulcer measuring 1.5cm in length, 1cm in breadth, and 4 cm in depth completely healed by 2 months of treatment. The utilization of <em>Apamarga kshara taila,</em> along with internal medications, has demonstrated significant efficacy in the management of DPU.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101167"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Naturopathy and yoga-based interventions modify risk factors of peripheral neuropathy and improve nerve conduction among Type-2 Diabetes Mellitus patients 自然疗法和瑜伽干预可以改变2型糖尿病患者周围神经病变的危险因素,改善神经传导
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-07-01 DOI: 10.1016/j.jaim.2025.101147
Koushik Gupta Somisetty , Geetha B. Shetty , K.J. Sujatha , Prashanth Shetty

Background

With the high prevalence of diabetic peripheral neuropathy among Type -2 Diabetes Mellitus (T2DM) patients, diagnosis and management of subclinical peripheral neuropathy are gaining concern to prevent its complications. A wide variety of alternative lifestyle interventions emphasizing improving glycemic control, promoting weight loss, and a prudent diet were found to be effective in improving nerve conduction abnormalities individually.

Objective

To study the impact of naturopathy and yoga intervention in the prevention and management of nerve damage among T2DM-associated neuropathic signs.

Methods

In this matched control trial (gender and age-matched), 76 patients with subclinical diabetic peripheral neuropathy were recruited to (i) Intervention Group (IG), n=38 who received naturopathy and yoga-based interventions for 9 days, (ii) Control Group (CG), n=38 continued regular oral hypoglycemic medications. Neuroelectrophysiological parameters like amplitude and velocity of bilateral median motor and sensory and deep peroneal nerve, fasting blood glucose, postprandial blood glucose Homeostatic Model for Insulin Resistance (HOMA-IR), steady state beta cell function (%B), and insulin sensitivity (%S) were assessed at baseline and after 9 days.

Results

Weight, BMI, FBG, HOMA-IR, and %S significantly (p<0.05) improved among IG. In comparison, FBG, PPBG, %S, right median sensory amplitude, and left median sensory nerve conduction velocity had shown a significant difference between the groups.

Conclusion

A significant reduction in modifiable risk factors of neuropathy like insulin resistance and weight after the intervention shows the effectiveness of lifestyle-based naturopathy and yoga intervention in preventing peripheral neuropathy among diabetics.
背景随着2型糖尿病(T2DM)患者中糖尿病周围神经病变的高发,亚临床周围神经病变的诊断和治疗越来越受到关注,以防止其并发症的发生。多种多样的生活方式干预强调改善血糖控制,促进体重减轻和谨慎的饮食被发现在改善神经传导异常方面是有效的。目的探讨自然疗法和瑜伽干预对t2dm相关神经病变体征神经损伤的防治作用。方法将76例亚临床糖尿病周围神经病变患者(性别和年龄匹配)纳入:(1)干预组(IG), n=38例接受自然疗法和瑜伽干预,为期9天;(2)对照组(CG), n=38例继续常规口服降糖药。在基线和9天后评估双侧正中运动神经、感觉神经和腓深神经的振幅和速度、空腹血糖、餐后血糖胰岛素抵抗稳态模型(HOMA-IR)、稳态β细胞功能(%B)和胰岛素敏感性(%S)等神经电生理参数。结果IG组患者体重、BMI、FBG、HOMA-IR、%S均显著改善(p < 0.05)。FBG、PPBG、%S、右侧正中感觉振幅、左侧正中感觉神经传导速度组间比较差异有统计学意义。结论干预后胰岛素抵抗、体重等神经病变可改变危险因素显著降低,表明生活方式自然疗法与瑜伽干预对糖尿病患者周围神经病变的预防效果显著。
{"title":"Naturopathy and yoga-based interventions modify risk factors of peripheral neuropathy and improve nerve conduction among Type-2 Diabetes Mellitus patients","authors":"Koushik Gupta Somisetty ,&nbsp;Geetha B. Shetty ,&nbsp;K.J. Sujatha ,&nbsp;Prashanth Shetty","doi":"10.1016/j.jaim.2025.101147","DOIUrl":"10.1016/j.jaim.2025.101147","url":null,"abstract":"<div><h3>Background</h3><div>With the high prevalence of diabetic peripheral neuropathy among Type -2 Diabetes Mellitus (T2DM) patients, diagnosis and management of subclinical peripheral neuropathy are gaining concern to prevent its complications. A wide variety of alternative lifestyle interventions emphasizing improving glycemic control, promoting weight loss, and a prudent diet were found to be effective in improving nerve conduction abnormalities individually.</div></div><div><h3>Objective</h3><div>To study the impact of naturopathy and yoga intervention in the prevention and management of nerve damage among T2DM-associated neuropathic signs.</div></div><div><h3>Methods</h3><div>In this matched control trial (gender and age-matched), 76 patients with subclinical diabetic peripheral neuropathy were recruited to (i) Intervention Group (IG), n=38 who received naturopathy and yoga-based interventions for 9 days, (ii) Control Group (CG), n=38 continued regular oral hypoglycemic medications. Neuroelectrophysiological parameters like amplitude and velocity of bilateral median motor and sensory and deep peroneal nerve, fasting blood glucose, postprandial blood glucose Homeostatic Model for Insulin Resistance (HOMA-IR), steady state beta cell function (%B), and insulin sensitivity (%S) were assessed at baseline and after 9 days.</div></div><div><h3>Results</h3><div>Weight, BMI, FBG, HOMA-IR, and %S significantly (p&lt;0.05) improved among IG. In comparison, FBG, PPBG, %S, right median sensory amplitude, and left median sensory nerve conduction velocity had shown a significant difference between the groups.</div></div><div><h3>Conclusion</h3><div>A significant reduction in modifiable risk factors of neuropathy like insulin resistance and weight after the intervention shows the effectiveness of lifestyle-based naturopathy and yoga intervention in preventing peripheral neuropathy among diabetics.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 4","pages":"Article 101147"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1